膈肌起搏治疗系统市场Share, Size, Trends, Industry Analysis Report, By Product (External Diaphragm Pacemaker, Diaphragm Pacemaker); By Application (SCI, ALS and Others); By Regions; Segment Forecast, 2020 - 2027

Report Summary

2019年，全球膈肌起搏治疗系统市场价值为490万美元，预计在预测期内复合年增长率为5.6%。膈肌起搏治疗的市场增长是由于越来越多的有创机械通气（IMV）并发症导致肺损伤、感染和肌肉萎缩。此外，随着脊髓损伤（SCI）和肌萎缩侧索硬化症（ALS）发病率的增加，该市场正呈现出有利可图的增长。

膈肌起搏是一种方法，以协助和支持人们谁面临的问题，在自己的呼吸。必要时可更换机械通风机。对先天性中枢性低通气综合征（CCHS）患者和颈髓巨大损伤患者是一种理想的治疗方法。

Know more about this report:样本页请求

产业动态

增长动力
The key market driving factors of global Diaphragm pacing therapy system market includes increasing prevalence of SCI (Spinal Cord Injuries) and rising occurrences of ALS (Amyotrophic lateral sclerosis). For instance, as per the National Spinal Cord Injury Statistical Center report in 2019, nearly 17,730 new SCI cases are accounted every year and nearly between 249,000 and 363,000 people are presently surviving with SCI in the U.S. Moreover, the global market is showing significant growth owing to rising technological advancements and rising product innovations and launches in the segment to thrive the market growth. The several benefits associated with diaphragm pacing therapy system like, less dependency on mechanical ventilators and allowing patients to breath more efficiently and naturally without the use of ventilators thrives the market growth in the forecast period.

此外，COVID-19病例数量的迅速增加导致了全球范围内对大量机械通气机的需求。膈肌起搏治疗系统是非常有用的治疗COVID-19患者，其中限制或非常少的机械通气可用。例如，在2020年7月，美国有近380万患者检测出冠状病毒阳性，而印度有近112万人患有冠状病毒。随着COVID-19数量的不断增加，预计在不久的将来膈肌起搏治疗系统将有巨大的需求。

膈肌起搏治疗系统市场报告范围

市场主要根据产品类型、应用和地理区域进行细分。

By Product type	By Application	By Region
外隔膜起搏器 Diaphragm Pacemaker	肌萎缩侧索硬化症 脊髓损伤 其他	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) Asia Pacific (Japan, China, India, South Korea) 拉丁美洲（巴西、墨西哥） MEA (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:样本页请求

Insight by Product Type

在产品类型上，全球市场分为外隔膜起搏器和隔膜起搏器。由于体外起搏器在先天性中枢性低通气综合征和颈椎病中的应用日益增多，因此在市场上占有主导地位。此外，隔膜起搏器减少了对停电的担忧，减少了对外部电源的需求，从而推动了这一细分市场的增长。这一细分市场还有其他一些优势，包括呼吸道感染的减少和患者流动性的增加，这些都推动了全球细分市场的增长。

Insight by Application

根据应用情况，全球市场分为脊髓损伤、肌萎缩侧索硬化等。由于每年SCI病例的数量和发病率不断上升，预计SCI部门将有显著增长。例如，根据国家脊髓损伤统计中心发布的报告，2018年美国有近288000人因脊髓损伤存活。此外，不断增加的交通事故、事故、体育/娱乐活动、跌倒，增加了SCI患者数量，并逐渐增加了对此类系统的需求。

此外，对于ALS患者的治疗，还需要巨大的横膈膜起搏治疗系统。这是由于肌萎缩侧索硬化症包括呼吸肌，如果治疗不当可能导致肺部疾病和呼吸障碍。此外，根据美国肌萎缩侧索硬化症协会的统计，2018年，每年约有5000名美国患者患有肌萎缩侧索硬化症。这给该领域的全球市场带来了丰厚的需求。

Geographic Overview

Geographically, the market is bifurcated into five major regions which include, North America, Europe, Asia Pacific, Latin America and MEA. North America is holds dominant market share in the growth of Diaphragm pacing therapy system. This growth is attributed due to rising government initiatives and support, surging COVID-19 cases in America and rising healthcare investment in the region. For instance, in July 2016, the Lungpacer Diaphragm Pacing System achieved the early market access status by the U.S. FDA, which assist the organization in nourishing and expanding its market position in the U.S.

Moreover, The Asia Pacific region is predicted to grow at a lucrative rate throughout the prediction period. The surging growth can be attributed due to the increasing R&D investments to develop technologically advanced healthcare infrastructure. Additionally, favorable government regulations also surge the market growth in the region. Rising per capita income of the region is also boosting the market growth of Diaphragm pacing therapy system in the near future.

此外,欧洲地区also contributes significant growth in the Diaphragm pacing therapy system market owing to the existence of vital service providers with enhanced and updated healthcare solutions. Additionally, rising new product launches and increasing healthcare infrastructure in the region shows impressive growth in Europe. European regions mainly include, Germany, Russia, France and Spain who contributes major share in the market. The relaxations in the government regulations and increasing assistance by the government bodies and several private institutions surge the market growth of Diaphragm pacing therapy system in the region. Moreover, rising awareness amongst the citizens regarding the treatment and Diaphragm pacing therapy system thrives the market growth in the region.

Competitive Insight

重点市场通过采取新产品发布、扩张、合资、合作、并购等有效方式，强调其在市场中的市场份额和产品组合，以改善和建立长期的市场足迹。全球市场的主要运营商包括Avery Biomedical Devices，Inc.、Lungpacer Medical、Atrotech、Synapse Biomedical等。